The Expanded Impact of Human Papillomavirus Vaccine

• Autores: Barbara A. Pahud, Kevin A. Ault
• Localización: Infectious disease clinics of North America, ISSN 0891-5520, Vol. 29, Nº. 4, 2015 (Ejemplar dedicado a: Pediatric Infectious Disease: Part II), págs. 715-724
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Human papilloma virus (HPV) infection is the most common sexually transmitted infection in the United States. Some infections will result in anogenital warts and anogenital or oropharyngeal cancers. Preventing HPV infection is a public health priority to reduce cancer and HPV-associated complications. Prevention through vaccination is the most cost-effective and lifesaving intervention to decrease the burden of HPV-related cancers and other HPV-associated diseases. It is critical for pediatricians to make a strong recommendation for early and timely vaccination and completion of the 3-dose series. The goal of early vaccination is to immunize before first exposure to HPV virus.